ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
2,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
5,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
9,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
11,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
13,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
14,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
15,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
16,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
16,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
17,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
18,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
19,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
19,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
20,1,Acne,Acnes,Skin appendage conditions,Skin,N
21,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
21,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
21,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
23,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
23,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
24,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
25,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
26,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
28,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
28,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
28,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
28,5,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
29,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
29,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
29,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
30,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
31,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
32,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
33,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
33,2,Pneumonia herpes viral,Herpes viral infections,Viral infectious disorders,Infec,Y
34,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
34,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
34,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
34,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
35,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
36,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
37,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
38,1,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
38,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
39,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
40,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
41,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
42,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
42,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
42,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
44,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
45,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
46,1,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
47,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
48,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
49,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
50,1,Vulvitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
51,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
52,1,Scrotal oedema,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
52,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
53,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
54,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
54,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
54,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
54,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
54,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
55,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
56,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
56,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Fistula of small intestine,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
58,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
59,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
60,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
61,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
62,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
62,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
62,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
64,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
64,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
65,1,Urticaria contact,Urticarias,Angioedema and urticaria,Skin,N
66,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
67,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
68,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
69,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
70,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
71,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
72,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
73,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
74,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
75,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
77,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
78,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
80,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
80,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
82,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
83,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
83,2,Headache,Headaches NEC,Headaches,Nerv,N
83,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
83,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
85,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
85,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
85,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
86,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
87,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
88,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
88,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
88,3,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
89,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
89,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
89,3,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
90,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
91,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
92,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
93,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
94,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
95,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
96,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
97,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
98,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
99,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
100,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
100,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
101,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
102,2,Headache,Headaches NEC,Headaches,Nerv,N
102,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
103,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
104,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
104,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
105,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
105,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
106,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
107,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
108,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
109,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
111,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
112,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
114,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
116,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
116,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
117,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
118,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
119,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
120,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
120,2,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
120,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
120,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
122,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
122,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
123,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
123,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
124,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
125,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
125,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
126,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
127,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,2,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
128,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
130,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
131,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
132,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
132,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
132,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
133,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
135,1,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
136,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
137,1,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
138,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
139,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
140,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
141,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
141,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
141,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
142,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
142,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
143,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
144,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
145,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
146,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
146,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
147,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
147,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
148,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
150,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
150,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
151,1,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
152,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
153,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
154,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
155,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
156,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
157,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
158,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
158,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
158,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
159,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
160,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
161,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
161,2,Headache,Headaches NEC,Headaches,Nerv,N
161,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
164,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
165,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
166,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
167,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
168,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
169,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
170,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
171,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
172,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
172,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
173,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
173,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
174,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
175,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
176,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
177,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
178,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
179,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
179,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
180,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
180,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
180,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
181,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
182,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
182,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
182,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
182,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
183,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
183,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
183,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
184,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
186,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
187,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
188,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
188,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
189,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
189,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
189,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
190,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
191,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
192,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
193,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
195,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
195,2,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
195,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
196,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
196,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
196,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
197,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
198,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
199,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
200,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
201,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
202,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
203,1,Headache,Headaches NEC,Headaches,Nerv,N
203,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
204,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
205,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
205,2,Headache,Headaches NEC,Headaches,Nerv,N
205,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
205,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
205,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
205,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
205,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
205,8,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
206,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
206,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
206,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
206,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
207,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
207,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
207,3,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
208,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
208,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
208,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
209,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
210,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
210,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
211,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
212,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
212,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
214,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
215,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
216,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
216,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
218,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
218,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
219,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
220,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
221,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
222,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
222,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
222,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
223,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
223,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
223,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
224,1,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
225,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
225,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
226,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
227,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
228,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
229,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
230,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
230,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
230,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
231,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
231,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
231,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
232,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
232,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
233,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
234,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
235,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
235,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
236,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
237,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
238,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
239,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
239,2,Precocious puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
240,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
241,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
242,1,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
243,1,Congenital hypothyroidism,Thyroid disorders congenital,Endocrine disorders congenital,Cong,N
244,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
245,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
245,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
246,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
246,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
246,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
247,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
247,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
247,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
247,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
248,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
249,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
250,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
250,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
251,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
251,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
251,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
252,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
252,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
253,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
254,1,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
255,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
256,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
257,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
258,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
258,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
258,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
259,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
260,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
260,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
260,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
261,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
261,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
262,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
263,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
263,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
264,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
265,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
266,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
267,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
268,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
268,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
269,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
269,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
270,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
270,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
271,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
271,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
271,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
272,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
273,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
273,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
274,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
274,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
274,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
274,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
274,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
275,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
275,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
275,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
276,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
276,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
277,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
277,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
278,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
278,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
279,1,Myopathy,Myopathies,Muscle disorders,Musc,N
280,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
281,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
281,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
281,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
281,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
281,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
282,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
282,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
282,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
282,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
282,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
283,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
283,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
283,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
283,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
283,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
285,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
286,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
287,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
288,1,Headache,Headaches NEC,Headaches,Nerv,N
289,1,Deafness permanent,Hearing losses,Hearing disorders,Ear,N
290,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
291,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
291,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
292,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
293,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
294,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
295,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
295,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
296,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
297,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
298,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
298,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
299,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
300,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
301,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
301,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
302,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
302,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
303,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
303,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
304,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
305,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
306,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
307,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
308,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
309,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
310,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
310,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
311,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
311,2,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
312,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
313,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
314,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
314,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
314,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
314,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
314,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
315,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
316,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
317,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
318,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
318,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
318,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
319,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
319,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
319,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
320,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
321,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
321,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,3,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
321,4,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
322,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
323,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
324,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
324,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
325,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
325,2,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
326,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
326,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
327,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
328,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
329,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
329,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
329,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
329,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
330,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
330,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
331,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
332,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
333,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
334,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
334,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
335,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
336,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
337,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
338,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
338,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
338,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
339,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
340,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
341,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
342,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
342,2,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
342,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
342,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
342,5,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
342,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
342,7,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
342,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
342,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
343,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
344,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
345,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
345,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
346,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
346,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
347,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
348,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
349,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
349,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
350,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
350,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
350,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
350,4,Oesophageal spasm,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
351,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
351,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
352,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
352,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
352,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
352,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
353,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
354,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
355,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
356,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
357,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
357,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
358,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
358,2,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
358,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
358,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
359,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
360,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
361,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
362,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
363,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
364,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
364,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
364,3,Headache,Headaches NEC,Headaches,Nerv,N
365,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
366,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
366,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
367,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
368,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
369,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
370,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
371,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
371,2,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
372,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
373,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
373,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
373,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
373,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
374,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
374,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
374,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
374,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
375,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
376,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
376,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
376,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
377,1,Headache,Headaches NEC,Headaches,Nerv,N
377,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
378,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
378,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
378,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
378,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
379,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
379,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
380,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
381,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
381,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
382,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
382,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
383,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
383,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
384,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
385,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
386,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
386,2,Ectropion,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
386,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
386,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
386,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
387,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
387,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
388,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
388,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
389,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
389,2,Rectal tenesmus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
390,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
390,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
391,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
391,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
391,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
393,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
394,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
394,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
394,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
395,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
395,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
395,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
396,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
396,2,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
397,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
397,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
398,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
398,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
398,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
399,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
400,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
400,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
401,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,2,Headache,Headaches NEC,Headaches,Nerv,N
402,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
402,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
402,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
402,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
403,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
404,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
405,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
406,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
406,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
407,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
408,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
409,1,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
410,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
411,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
412,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
413,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
414,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
415,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
416,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
417,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
418,1,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
419,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
419,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
420,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
420,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
421,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
422,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
423,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
423,2,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
424,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
426,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
426,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
427,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
428,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
428,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
429,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
430,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
430,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
431,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
432,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
433,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
434,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
435,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
436,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
437,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
438,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
439,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
440,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
440,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
441,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
441,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
442,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
443,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
444,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
444,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
444,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
444,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
445,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
446,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
446,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
447,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
448,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
448,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
448,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
449,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
449,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
449,3,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
449,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
450,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
451,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
451,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
452,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
453,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
453,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
453,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
454,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
455,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
457,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
458,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
458,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
459,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
460,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
460,2,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
461,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
461,2,Glucocorticoids increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
462,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
462,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
462,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
463,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
464,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
465,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
466,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
466,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
467,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
467,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
468,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
469,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
470,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
470,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
470,3,Myopathy,Myopathies,Muscle disorders,Musc,N
471,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
471,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
471,3,Myopathy,Myopathies,Muscle disorders,Musc,N
472,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
472,2,Myopathy,Myopathies,Muscle disorders,Musc,N
473,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
473,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
474,1,Myopathy,Myopathies,Muscle disorders,Musc,N
474,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
475,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
476,1,Myopathy,Myopathies,Muscle disorders,Musc,N
477,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
478,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
478,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
479,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
480,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
481,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
481,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
481,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
482,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
482,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
483,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
483,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
483,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
484,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
484,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
485,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
486,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
486,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
487,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
488,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
488,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
488,3,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
488,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
489,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
490,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
491,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
491,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
492,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
492,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
492,3,Rectal tenesmus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
493,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
494,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
495,1,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
496,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
496,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
497,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
498,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
499,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
500,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
500,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
500,3,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
500,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
501,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
502,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
502,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
503,1,Headache,Headaches NEC,Headaches,Nerv,N
504,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
505,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
505,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
506,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
506,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
506,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
506,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
507,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
508,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
509,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
509,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
511,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
512,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
513,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
514,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
515,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
516,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
516,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
516,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
516,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
517,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
518,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
519,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
520,1,Deafness congenital,Hearing disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
521,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
522,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
523,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
523,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
523,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
524,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
524,2,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
525,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
526,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
527,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
528,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
529,1,Vulvovaginitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
530,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
531,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
531,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
532,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
532,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
532,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
533,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
534,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
535,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
535,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
536,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
537,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
538,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
538,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
539,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
540,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
541,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
541,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
542,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
542,2,Headache,Headaches NEC,Headaches,Nerv,N
542,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
543,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
543,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
543,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
544,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
544,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
545,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
545,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
545,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
546,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
547,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
547,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
548,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
549,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
550,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
551,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
551,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
552,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
553,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
553,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
554,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
555,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
555,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
555,3,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
556,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
556,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
556,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
556,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
556,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
557,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
557,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
557,3,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
557,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
557,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
558,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
558,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
558,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
558,4,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
558,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
558,6,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
559,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
559,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
560,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
561,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
562,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
563,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
563,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
563,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
563,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
563,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
563,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
564,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
564,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
565,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
565,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
565,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
566,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
567,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
567,2,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
568,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
569,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
569,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
569,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
569,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
569,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
570,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
571,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
572,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
572,2,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
572,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
572,4,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
572,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
572,6,Male reproductive tract disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
572,7,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
572,8,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
573,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
573,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
573,3,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,Y
574,1,Gastrointestinal ulcer perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
575,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
576,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
577,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
578,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
578,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
578,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
579,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
580,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
580,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
580,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
580,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
581,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
581,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
581,3,Hyperthermia malignant,Body temperature altered,Body temperature conditions,Genrl,Y
581,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
582,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
583,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
583,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
584,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
585,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
586,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
586,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
587,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
587,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
587,3,Type III immune complex mediated reaction,Allergic conditions NEC,Allergic conditions,Immun,N
588,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
589,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
590,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
591,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
592,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
593,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
593,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
594,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
594,2,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
594,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
594,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
594,5,Large intestinal stenosis,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
594,6,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
594,7,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
594,8,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
594,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
595,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
595,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
597,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
598,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
598,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
599,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
599,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
599,3,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
599,4,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
599,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
600,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
600,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
600,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
601,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
601,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
601,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
601,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
601,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
602,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
602,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
602,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
603,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
603,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
603,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
603,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
604,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
605,1,Ear deformity acquired,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
605,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
605,3,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
606,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
606,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
607,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
607,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
607,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
608,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
609,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
610,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
611,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
612,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
613,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
613,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
613,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
613,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
613,5,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
613,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
613,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
613,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
614,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
614,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
614,3,Blood prolactin decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
614,4,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
614,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
614,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
614,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
614,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
614,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
614,10,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
614,11,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
614,12,Headache,Headaches NEC,Headaches,Nerv,N
614,13,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
614,14,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
614,15,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
614,16,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
614,17,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
614,18,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
614,19,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
614,20,Pituitary infarction,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
614,21,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
614,22,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
615,1,Application site atrophy,Application site reactions,Administration site reactions,Genrl,N
616,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
617,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
618,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
618,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
618,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
619,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
619,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
619,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
620,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
620,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
620,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
620,4,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
621,1,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
621,2,Eyelid exfoliation,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
621,3,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
621,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
622,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
623,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
623,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
624,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
624,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
624,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
624,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
624,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
625,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
626,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
626,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
626,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
627,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
628,1,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
629,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
629,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
629,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
629,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
629,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
629,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
630,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
630,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
630,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
631,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
631,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
632,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
632,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
632,3,Posterior capsule opacification,"Lens structural change, deposit and degeneration (excl cataracts)","Anterior eye structural change, deposit and degeneration",Eye,N
633,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
633,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
633,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
633,4,Headache,Headaches NEC,Headaches,Nerv,N
633,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
634,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
634,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
635,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
636,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
636,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
636,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
637,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
637,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
637,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
637,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
637,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
638,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
638,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
639,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
639,2,Tachycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
640,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
640,2,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
640,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
640,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
640,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
641,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
641,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
641,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
641,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
642,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
642,2,Headache,Headaches NEC,Headaches,Nerv,N
642,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
642,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
643,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
643,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
643,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
644,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
644,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
645,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
645,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
645,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
645,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
645,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
645,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
645,7,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
646,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
646,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
646,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
646,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
646,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
646,6,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
646,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
646,8,Somatic symptom disorder of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
646,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
646,10,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
647,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
647,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
648,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
649,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
650,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
651,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
652,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
652,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
653,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
653,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
653,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
654,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
654,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
654,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
654,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
654,5,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
654,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
654,7,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
654,8,Phaeochromocytoma,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
654,9,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
654,10,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
655,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
656,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
657,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
657,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
658,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
658,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
658,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
658,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
658,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
658,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
659,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
660,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
660,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
660,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
661,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
662,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
663,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
663,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
663,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
663,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
663,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
663,6,Tinea pedis,Tinea infections,Fungal infectious disorders,Infec,N
664,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
665,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
666,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
667,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
667,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
667,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
667,4,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
667,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
667,6,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
667,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
667,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
667,9,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
667,10,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
667,11,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
667,12,Urine albumin/creatinine ratio abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
668,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
668,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
668,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
668,4,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
669,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
669,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
669,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
669,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
669,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
669,6,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
670,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
671,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
672,1,Spinal fusion surgery,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
673,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
673,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
674,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
674,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
674,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
674,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
675,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
676,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
676,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
677,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
678,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
678,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
678,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
678,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
678,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
679,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
679,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
679,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
679,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
679,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
680,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
680,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
680,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
680,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
680,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
680,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
681,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
681,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
682,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
683,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
683,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
683,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
683,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
684,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
684,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
684,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
684,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
685,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
685,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
685,3,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
685,4,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
685,5,Benign neoplasm of adrenal gland,Adrenal neoplasms benign,Endocrine neoplasms benign,Neopl,N
685,6,Blood corticotrophin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
685,7,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
685,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
685,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
686,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
686,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
686,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
686,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
686,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
686,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
686,7,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
686,8,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
686,9,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
686,10,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,Y
686,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
686,12,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
686,13,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
686,14,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
686,15,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
686,16,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
687,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
687,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
687,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
687,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
688,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
688,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
688,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
688,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
689,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
689,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
689,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
690,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
691,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
692,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
692,2,Blood corticotrophin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
692,3,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
692,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
692,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
692,6,Glucocorticoids decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
692,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
692,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
692,9,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
692,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
693,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
693,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
693,3,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
693,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
693,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
693,6,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
694,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
694,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
695,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
695,2,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
696,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
697,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
697,2,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
698,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
698,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
698,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
698,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
698,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
698,6,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
698,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
698,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
698,9,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
698,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
698,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
698,12,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
698,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
699,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
700,1,Face injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
700,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
700,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
700,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
700,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
701,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
702,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
702,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
702,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
702,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
703,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
703,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
704,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
705,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
705,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
706,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
706,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
706,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
706,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
707,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
707,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
708,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
708,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
709,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
709,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
709,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
710,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
710,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
710,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
710,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
710,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
710,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
710,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
710,8,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
710,9,Headache,Headaches NEC,Headaches,Nerv,N
710,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
710,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
710,12,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
710,13,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
710,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
711,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
711,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
711,3,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
711,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
711,5,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
711,6,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
711,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
712,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
713,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
713,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
713,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
713,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
713,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
713,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
713,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
714,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
715,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
715,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
715,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
716,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
716,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
717,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
717,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
718,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
718,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
719,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
720,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
720,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
720,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
720,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
720,5,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
720,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
720,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
721,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
721,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
721,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
721,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
721,5,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
721,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
722,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
722,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
722,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
722,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
722,5,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
722,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
722,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
723,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
723,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
724,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
724,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
724,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
724,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
725,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
725,2,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
725,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
725,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
726,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
726,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
726,3,Propofol infusion syndrome,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
726,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
727,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
727,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
727,3,Propofol infusion syndrome,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
727,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
728,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
728,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
728,3,Propofol infusion syndrome,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
728,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
729,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
729,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
729,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
729,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
730,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
730,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
731,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
731,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
731,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
732,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
733,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
733,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
734,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
735,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
735,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
735,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
735,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
735,5,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
735,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
735,7,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
735,8,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
735,9,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
735,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
735,11,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
735,12,Pelvic fluid collection,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
735,13,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
735,14,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
735,15,Speech sound disorder,Communications disorders,Communication disorders and disturbances,Psych,N
735,16,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
735,17,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
736,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
736,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
736,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
736,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
736,5,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
736,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
736,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
737,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
737,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
738,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
738,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
739,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
739,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
739,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
739,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
740,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
740,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
740,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
740,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
741,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
742,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
742,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
742,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
742,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
742,5,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
742,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
743,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
743,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
744,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
744,2,Pregnancy on oral contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
745,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
745,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
745,3,Ear injury,Ear injuries NEC,Injuries NEC,Inj&P,N
745,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
745,5,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
745,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
745,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
746,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
746,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
746,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
746,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
746,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
746,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
746,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
746,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
747,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
747,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
747,3,Rectal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
748,1,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
748,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
748,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
749,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
750,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
751,1,Infertility male,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
751,2,Sperm concentration decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
752,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
753,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
753,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
754,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
754,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
754,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
754,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
754,5,Nephritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
754,6,Nitrite urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
754,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
754,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
754,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
754,10,White blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
755,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
755,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
755,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
755,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
755,5,Conjunctival irritation,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
755,6,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
755,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
755,8,Nikolsky's sign,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
755,9,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
755,10,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
755,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
755,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
755,13,Pseudomonas test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
755,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
755,15,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,16,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
755,17,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
756,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
756,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
756,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
756,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
756,5,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
756,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
756,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
757,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
758,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
759,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
759,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
759,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
759,4,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
759,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
759,6,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
759,7,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
759,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
759,9,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
759,10,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
759,11,Gastric hypomotility,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
759,12,Infrequent bowel movements,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
759,13,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
759,14,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
759,15,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
759,16,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
759,17,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
759,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
759,19,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
760,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
760,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
760,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
760,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
760,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
761,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
761,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
761,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
761,4,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
762,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
762,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
762,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
762,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
762,5,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
762,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
762,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
762,8,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
762,9,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
762,10,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
762,11,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
763,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
763,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
763,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
764,1,Headache,Headaches NEC,Headaches,Nerv,N
765,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
765,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
765,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
765,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
765,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
765,6,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
765,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
765,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
765,9,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
765,10,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
765,11,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
765,12,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
766,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
767,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
767,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
768,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
768,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
768,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
769,1,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
770,1,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
770,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
770,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
771,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
772,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
773,1,Headache,Headaches NEC,Headaches,Nerv,N
774,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
774,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
775,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
775,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
775,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
776,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
776,2,Adrenocorticotropic hormone deficiency,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
776,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
776,4,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
776,5,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
776,6,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
776,7,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
776,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
776,9,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
776,10,Hyperaemia,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
776,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
776,12,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
776,13,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
776,14,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
776,15,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
776,16,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
776,17,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
777,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
778,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
778,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
778,3,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
778,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
778,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
779,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
779,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
779,3,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
779,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
779,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
780,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
780,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
781,1,Conjunctivitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
781,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
781,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
781,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
781,5,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
781,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
782,1,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
783,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
783,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
784,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
784,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
784,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
784,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
784,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
785,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
786,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
786,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
787,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
788,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
788,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
788,3,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
788,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
788,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
788,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
788,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
789,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
790,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
790,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
790,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
790,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
790,5,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
790,6,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
791,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
792,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
792,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
793,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
794,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
795,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
796,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
796,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
796,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
796,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
796,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
796,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
796,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
796,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
797,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
798,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
798,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
799,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
799,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
799,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
800,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
801,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
802,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
803,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
803,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
803,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
803,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
804,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
805,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
805,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
805,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
805,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
806,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
806,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
806,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
806,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
806,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
807,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
807,2,Middle cerebral artery stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
808,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
809,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
810,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
811,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
811,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
812,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
812,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
813,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
814,1,Dark circles under eyes,Ocular disorders NEC,Eye disorders NEC,Eye,N
814,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
814,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
814,4,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
814,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
814,6,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
814,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
814,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
814,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
814,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
814,11,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
814,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
815,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
815,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
815,3,Penile erythema,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
815,4,Penile pain,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
815,5,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
816,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
816,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
816,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
817,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
818,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
818,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
819,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
819,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
819,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
820,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
820,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
821,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
821,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
821,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
822,1,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
822,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
822,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
822,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
822,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
822,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
822,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
822,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
822,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
822,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
822,11,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
822,12,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
822,13,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
822,14,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
822,15,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
823,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
824,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
824,2,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
824,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
824,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
824,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
825,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
825,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
826,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
826,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
827,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
827,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
827,3,Excessive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
827,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
827,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
828,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
828,2,Injection site joint movement impairment,Injection site reactions,Administration site reactions,Genrl,N
828,3,Injection site joint pain,Injection site reactions,Administration site reactions,Genrl,N
828,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
828,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
828,6,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
829,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
829,2,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
829,3,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
829,4,Product coating issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
830,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
830,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
831,1,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
831,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
832,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
832,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
832,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
833,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
834,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
834,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
834,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
835,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
835,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
835,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
835,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
835,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
836,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
836,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
837,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
837,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
837,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
837,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
837,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
838,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
838,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
838,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
839,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
839,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
839,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
840,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
840,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
840,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
841,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
841,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
841,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
841,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
842,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
842,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
842,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
842,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
842,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
842,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
842,7,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
842,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
842,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
842,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
843,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
843,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
843,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
844,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
845,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
846,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
846,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
846,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
846,4,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
846,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
846,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
847,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
847,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
847,3,Inflammation of wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
847,4,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
847,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
848,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
848,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
848,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
848,4,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
848,5,Cardiac failure,Heart failures NEC,Heart failures,Card,N
848,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
848,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
848,8,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
848,9,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
848,10,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
848,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
848,12,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
848,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
848,14,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
848,15,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
848,16,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
848,17,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
849,1,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
850,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
850,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
851,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
852,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
852,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
853,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
854,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
854,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
854,3,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
854,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
854,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
854,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
854,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
854,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
854,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
854,10,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
855,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
855,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
855,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
855,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
855,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
856,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
856,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
856,3,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
856,4,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
856,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
856,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
857,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
857,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
857,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
858,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
858,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
859,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
859,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
860,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
860,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
860,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
860,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
860,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
861,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
861,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
862,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
862,2,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
862,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
862,4,Wound infection pseudomonas,Pseudomonal infections,Bacterial infectious disorders,Infec,N
863,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,Y
863,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
863,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
863,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
863,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
864,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
864,2,Finger deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
864,3,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
864,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
864,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
864,6,Normal tension glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
864,7,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
865,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
866,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
866,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
866,3,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
867,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
868,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
868,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
868,3,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,N
868,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
869,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
869,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
869,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
869,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
869,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
869,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
869,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
869,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
869,9,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
869,10,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
869,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
869,12,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
869,13,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
870,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
871,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
872,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
873,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
873,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
873,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
873,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
874,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
874,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
874,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
875,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
876,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
876,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
876,3,Haemorrhage urinary tract,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
877,1,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
877,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
877,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
877,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
877,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
878,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
878,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
878,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
879,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
879,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
879,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
880,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
880,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
880,4,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
880,5,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
880,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
880,7,Lacrimation decreased,Lacrimation disorders,Eye disorders NEC,Eye,N
880,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
880,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
880,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
881,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
881,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
881,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
882,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
882,4,Headache,Headaches NEC,Headaches,Nerv,N
882,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
882,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
882,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
883,1,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
884,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
885,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
885,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
885,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
885,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
886,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
886,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
886,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
887,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
888,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
888,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
889,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
889,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
890,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
890,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
890,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
891,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
892,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
892,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
892,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
893,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
894,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
895,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
895,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
895,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
895,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
895,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
896,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
896,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
896,3,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
896,4,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
896,5,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
896,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
896,7,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
896,8,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
896,9,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
896,10,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
896,11,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
896,12,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
896,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
896,14,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
897,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
897,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
898,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
898,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
898,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
898,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
899,1,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
899,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
899,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
900,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
901,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
901,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
901,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
902,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
902,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
903,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
904,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
904,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
905,1,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
906,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
906,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
907,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
907,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
907,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
907,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
907,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
908,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
908,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
909,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
910,1,Epidural lipomatosis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
910,2,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
910,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
910,4,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
911,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
911,2,Myopathy,Myopathies,Muscle disorders,Musc,N
911,3,Respiratory muscle weakness,Thoracic musculoskeletal disorders,Thoracic disorders (excl lung and pleura),Resp,N
912,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
913,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
913,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
913,3,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
914,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
914,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
914,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
915,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
915,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
915,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
915,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
916,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
916,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
916,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
917,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
917,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
917,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
917,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
918,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
918,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
918,3,Haemodialysis complication,Dialysis related complications,Procedural related injuries and complications NEC,Inj&P,N
918,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
918,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
918,6,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
918,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
918,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
919,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
919,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
920,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
920,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
920,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
920,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
921,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
922,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
922,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
923,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
923,2,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
923,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
924,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
924,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
925,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
925,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
925,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
926,1,Abscess rupture,Infections NEC,Infections - pathogen unspecified,Infec,N
926,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
926,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
926,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
926,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
926,6,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
927,1,Airway peak pressure increased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
927,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
927,3,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
927,4,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
927,5,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
927,6,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
927,7,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
927,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
927,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
927,10,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
927,11,Lung hyperinflation,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
927,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
927,13,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
927,14,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
927,15,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
927,16,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
927,17,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
927,18,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
928,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
928,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
929,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
929,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
929,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
929,4,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
930,1,Penile blister,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
931,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
931,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
931,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
932,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
932,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
933,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
933,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
933,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
934,1,Anal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
934,2,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
935,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
935,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
935,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
936,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
937,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
937,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
937,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
938,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
938,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
938,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
938,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
938,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
938,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
938,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
939,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
939,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
939,3,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
939,4,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
939,5,Ketosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
939,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
939,7,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
940,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
941,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
941,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
941,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
941,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
941,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
942,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
942,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
942,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
942,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
943,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
944,1,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
944,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
944,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
944,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
944,5,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
944,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
944,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
944,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
945,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
945,2,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
945,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
945,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
945,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
945,6,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
945,7,Hypothalamic pituitary adrenal axis suppression,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
945,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
946,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
946,2,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
946,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
946,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
946,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
946,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
946,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
946,8,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
946,9,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
947,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
947,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
947,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
947,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
947,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
948,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
948,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
948,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
948,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
948,5,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
948,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
948,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
948,8,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
949,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
950,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
950,2,Dermal cyst,Skin cysts and polyps,Cutaneous neoplasms benign,Skin,N
951,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
951,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
951,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
951,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
951,5,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
951,6,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
952,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
952,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
952,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
952,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
952,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
953,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
954,1,Acne,Acnes,Skin appendage conditions,Skin,N
954,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
954,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
955,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
955,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
955,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
955,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
956,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
957,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
957,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
957,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
958,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
958,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
958,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
958,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
958,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
958,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
959,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
959,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
959,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
960,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
961,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
961,2,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
961,3,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
962,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
963,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
963,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
963,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
963,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
963,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
963,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
963,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
963,8,Migraine with aura,Migraine headaches,Headaches,Nerv,N
963,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
963,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
963,11,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
963,12,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
964,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
964,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
964,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
965,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
965,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
966,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
966,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
966,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
966,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
966,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
966,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
966,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
966,8,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
966,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
967,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
967,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
967,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
967,4,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
967,5,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
968,1,Rectal discharge,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
969,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
969,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
970,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
970,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
970,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
971,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
971,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
971,3,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
971,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
972,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
972,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
973,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
973,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
973,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
973,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
973,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
973,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
974,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
974,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
975,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
975,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
975,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
975,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
975,5,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
975,6,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
975,7,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
975,8,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
975,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
976,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
976,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
977,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
977,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
978,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
978,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
978,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
978,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
979,1,Acne,Acnes,Skin appendage conditions,Skin,N
979,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
979,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
979,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
979,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
979,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
979,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
979,8,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
980,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
980,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
980,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
981,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
981,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
982,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
982,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
983,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
983,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
983,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
984,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
985,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
985,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
985,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
985,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
985,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
985,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
986,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
986,2,Dermatitis diaper,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
987,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
987,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
987,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
988,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
988,2,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
989,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
989,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
990,1,Airway peak pressure increased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
990,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
990,3,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
990,4,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
990,5,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
990,6,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
990,7,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
990,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
990,9,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
990,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
990,11,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
990,12,Lung hyperinflation,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
990,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
990,14,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
990,15,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
990,16,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
990,17,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
990,18,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
990,19,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
991,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
991,2,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
992,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
992,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
992,3,Product outer packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
993,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
994,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
995,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
995,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
995,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
995,4,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
995,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
995,6,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
996,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
996,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
996,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
996,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
996,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
996,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
996,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
996,8,Phaeochromocytoma crisis,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,Y
997,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
997,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
997,3,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
997,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
997,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
997,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
998,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
999,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
999,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1000,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1000,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
1001,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1001,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1002,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
1003,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1003,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1003,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1004,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1004,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1005,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1006,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1007,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1007,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1007,3,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1007,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1007,5,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1007,6,Urethral pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1007,7,Urinary tract injury,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1008,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1008,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1009,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1009,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1009,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1010,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
1011,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1011,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1011,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1012,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1012,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1012,3,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
1012,4,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1013,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1013,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1013,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1013,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1014,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1014,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1015,1,Adrenogenital syndrome,Adrenal disorders congenital,Endocrine disorders congenital,Cong,N
1015,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1015,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1015,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1016,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1016,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1016,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1016,4,Precocious puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
1017,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1018,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1018,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1018,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1018,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1018,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1019,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1019,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1019,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1020,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1021,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1022,1,Migraine,Migraine headaches,Headaches,Nerv,N
1023,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1023,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1023,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1023,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1024,1,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1024,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1025,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1026,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1026,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1026,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1027,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1027,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1027,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1027,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1027,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1027,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1027,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1027,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1028,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1029,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
1030,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1030,2,Airway peak pressure increased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1030,3,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1030,4,Asthmatic crisis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1030,5,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1030,6,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1030,7,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1030,8,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1030,9,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1030,10,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1030,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1030,12,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1030,13,Lung hyperinflation,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1030,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1030,15,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1030,16,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1030,17,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1030,18,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1030,19,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1030,20,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1031,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1031,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1032,1,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1032,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1032,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1033,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1033,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1033,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1033,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1033,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1033,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1034,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1034,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1034,3,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1035,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1035,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1035,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1035,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1035,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1035,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1036,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1037,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1038,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1039,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1039,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1040,1,Headache,Headaches NEC,Headaches,Nerv,N
1040,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1040,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1041,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1041,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1042,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1043,1,Application site hypoaesthesia,Application site reactions,Administration site reactions,Genrl,N
1044,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1045,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1045,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1045,3,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
1045,4,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1045,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1045,6,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1046,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1046,2,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1047,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1047,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1047,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1047,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1048,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1049,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1049,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1050,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1051,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1051,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1051,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1051,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1051,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1051,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1051,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1051,8,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1051,9,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1052,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1052,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1053,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1053,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1054,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1055,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1055,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1055,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1055,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1055,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1055,6,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1055,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1055,8,Eyelid function disorder,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1055,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1055,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1055,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1055,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1055,13,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1056,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1056,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1056,3,Myocardial stunning,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1057,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1057,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1057,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1057,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1057,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1057,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1057,7,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1057,8,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1057,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1057,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1058,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1059,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1059,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1060,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1061,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1061,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1061,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1061,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1062,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1063,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1063,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1063,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1064,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1064,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1065,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1065,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1065,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1065,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1066,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1066,3,Headache,Headaches NEC,Headaches,Nerv,N
1066,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1066,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1067,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1067,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1067,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1067,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1067,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1067,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1067,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1067,8,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1067,9,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1067,10,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1067,11,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1067,12,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1067,13,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1067,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1067,15,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1067,16,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1067,17,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1067,18,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1067,19,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1067,20,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1067,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1068,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1068,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1069,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1069,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1069,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1069,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1069,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1069,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
1069,7,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1069,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1069,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1069,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1069,11,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1070,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1070,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1070,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1070,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1071,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1071,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1072,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1072,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1073,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1073,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1073,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1074,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1074,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1075,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1075,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1076,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1077,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1077,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1078,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1078,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1078,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1079,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1079,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1079,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1079,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1079,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1079,6,Mallory-Weiss syndrome,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1080,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1080,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1081,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1081,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1081,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1082,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1083,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1084,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1084,2,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1084,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1084,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1084,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1085,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1085,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1086,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1086,2,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
1086,3,Spinal cord disorder,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1086,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1087,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1087,2,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1087,3,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1087,4,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1087,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1087,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1087,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1088,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1088,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1089,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1089,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1089,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1089,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1089,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
1089,6,Respiratory tract haemorrhage,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1089,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1090,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1090,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1090,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1090,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1090,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1091,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1091,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1092,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1093,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1093,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1093,3,Tonic clonic movements,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1094,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1094,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1095,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1095,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1095,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1095,4,Discoloured vomit,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1095,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1095,6,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1095,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1096,1,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1096,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1096,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1097,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1097,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1097,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1097,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1097,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1097,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1097,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1097,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1097,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1097,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1097,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1097,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1097,13,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1097,14,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1098,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1098,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1098,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1098,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1098,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1098,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1098,7,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1098,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1098,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1098,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1099,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1099,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1100,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1101,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1101,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1101,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1101,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1101,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1102,1,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
1102,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1103,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1103,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1104,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1104,2,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1105,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1106,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1106,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1106,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1107,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1108,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1108,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1108,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1109,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1109,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1109,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1109,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1109,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1110,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1110,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1110,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1110,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1111,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1112,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1112,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1113,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1113,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1113,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1113,4,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1113,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1113,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1113,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1114,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1115,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1115,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1115,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1116,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1116,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1116,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1116,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1116,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1117,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1118,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1118,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1118,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1119,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1120,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1120,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1120,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1120,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1121,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1121,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1121,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1121,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1121,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1121,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1121,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1121,8,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1121,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1121,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1122,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1123,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1123,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1123,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1124,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1124,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1124,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1124,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1124,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1124,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1125,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
1125,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1125,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1125,4,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1125,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1126,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1126,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1126,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1127,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1127,2,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1128,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1128,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1128,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1129,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1130,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1131,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1131,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1132,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1132,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1132,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1132,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1132,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1132,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1133,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1133,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1133,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1133,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1133,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1134,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1134,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1134,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1134,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1134,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1135,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1135,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1136,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1136,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1136,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1136,4,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1137,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1137,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1137,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1137,4,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1137,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1138,1,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,Y
1139,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
1139,2,Adrenocorticotropic hormone deficiency,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
1139,3,Bone marrow oedema syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
1139,4,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1139,5,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1139,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1139,7,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1139,8,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1139,9,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1139,10,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1139,11,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1139,12,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1139,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1140,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1140,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1140,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1141,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
1142,1,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
1143,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1144,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1144,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1145,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1146,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1146,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1146,3,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1146,4,Penile erythema,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
1146,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1146,6,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1146,7,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1146,8,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1146,9,Tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1147,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1147,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1147,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1147,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1147,5,Pregnancy with injectable contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1148,1,Acne,Acnes,Skin appendage conditions,Skin,N
1149,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1149,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1149,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1149,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1150,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
1151,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1151,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1151,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1151,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1151,5,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1151,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1151,7,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1151,8,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1151,9,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1151,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1151,11,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1151,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1152,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1153,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1154,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1154,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1154,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1154,4,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
1154,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1154,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1154,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1154,8,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1154,9,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1154,10,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1154,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1154,12,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1154,13,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1154,14,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1154,15,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1154,16,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1154,17,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1154,18,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1154,19,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1154,20,Multimorbidity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1154,21,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1154,22,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1154,23,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1154,24,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1154,25,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1154,26,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1154,27,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1154,28,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1154,29,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1154,30,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1154,31,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1154,32,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1154,33,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1154,34,Soft tissue mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1154,35,Superinfection,Infections NEC,Infections - pathogen unspecified,Infec,N
1154,36,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1154,37,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1154,38,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1155,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1156,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1156,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1156,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1156,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1157,1,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1157,2,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
1157,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1157,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1158,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
1159,1,External ear inflammation,External ear infections and inflammations,External ear disorders (excl congenital),Ear,N
1159,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1159,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1160,1,Exposure via eye contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1160,2,Injury corneal,Eye injuries NEC,Injuries NEC,Inj&P,N
1160,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1161,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1161,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1162,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1163,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1164,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1165,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1165,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1165,3,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
1165,4,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1165,5,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1165,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1165,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1165,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1165,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1165,10,Idiopathic angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1165,11,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1165,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1165,13,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1165,14,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1165,15,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1165,16,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1165,17,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1165,18,Rebound eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1165,19,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1165,20,Respiratory tract oedema,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1165,21,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1165,22,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1165,23,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1165,24,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1165,25,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1165,26,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1165,27,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1165,28,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1166,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1167,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1167,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1168,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1168,2,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
1168,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1168,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1168,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1168,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1168,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1169,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
1169,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1169,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1169,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1169,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1169,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1169,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1169,8,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1169,9,Lymphatic disorder,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1169,10,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1169,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1169,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1169,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1169,14,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1169,15,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1169,16,Tachyphylaxis,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1170,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1170,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1170,3,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1170,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1171,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1171,2,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1171,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1171,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1172,1,Headache,Headaches NEC,Headaches,Nerv,N
1172,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1173,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1173,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1173,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1173,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1173,5,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1174,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1174,2,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
1174,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1174,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1174,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1174,6,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1174,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1174,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1174,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1174,10,Post-traumatic stress disorder,Stress disorders,Anxiety disorders and symptoms,Psych,N
1174,11,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1174,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1174,13,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1174,14,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1174,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1174,16,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1174,17,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1174,18,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1174,19,Social anxiety disorder,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1174,20,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1174,21,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1174,22,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1175,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1175,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1175,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1175,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1175,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1175,6,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1175,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1175,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1175,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1176,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1176,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1176,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1176,4,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1176,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1176,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1176,7,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1176,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1176,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1176,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1177,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
1177,2,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1177,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1177,4,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1177,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1177,6,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1177,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1177,8,Lip disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1177,9,Lip exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1177,10,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1177,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1177,12,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1177,13,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1177,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1177,15,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1177,16,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1178,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1178,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1178,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1178,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1178,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1178,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1178,7,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1178,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1178,9,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1178,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1178,11,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1178,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1178,13,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1178,14,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1178,15,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1178,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1178,17,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1178,18,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1178,19,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1179,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1179,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1179,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1179,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1179,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1179,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1179,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1179,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1179,9,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1179,10,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1179,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1179,12,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1179,13,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1180,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1180,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1180,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1180,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1180,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1180,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1180,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1180,8,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1180,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1181,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1181,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1181,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1181,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1181,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1181,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1181,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1181,8,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1181,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1181,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1181,11,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1181,12,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1181,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1181,14,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1181,15,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1181,16,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1181,17,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1182,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1182,2,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1182,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1182,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1182,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1182,6,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1182,7,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1182,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1183,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1183,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1183,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1183,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1184,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1184,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1184,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1185,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1185,2,Product contamination microbial,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1185,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1185,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1186,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1186,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1186,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1186,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1186,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1186,6,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1186,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1186,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1186,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1186,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1186,11,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1186,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1186,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1186,14,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1186,15,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1186,16,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1186,17,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1186,18,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1186,19,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1186,20,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1186,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1187,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1188,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1188,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1188,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1188,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1189,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1190,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1190,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1190,3,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1191,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1192,1,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1192,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1192,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1192,4,Headache,Headaches NEC,Headaches,Nerv,N
1192,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1192,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1192,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1192,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1192,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1192,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1192,11,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1192,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1193,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1194,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1195,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1195,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1196,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1196,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1197,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1197,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1197,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1197,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1197,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1197,6,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1197,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1197,8,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1198,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1198,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1198,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1199,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1199,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1199,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1199,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1199,5,Female sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1199,6,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1199,7,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1199,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1199,9,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1199,10,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1199,11,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1200,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1200,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1201,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1201,2,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1201,3,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1201,4,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1201,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1201,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1202,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1202,2,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1202,3,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1202,4,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1202,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1202,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1203,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1203,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1204,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1204,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1204,3,Madarosis,Alopecias,Skin appendage conditions,Skin,N
1204,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1204,5,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1204,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1204,7,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1204,8,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1205,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
1206,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1206,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1207,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1207,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1207,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1207,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1207,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1207,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1207,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1207,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1207,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1207,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1207,11,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1208,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1208,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1208,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1209,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1209,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1209,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1210,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1210,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1211,1,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
1211,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1211,3,Burns third degree,Thermal burns,Injuries by physical agents,Inj&P,N
1211,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1211,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1211,6,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1211,7,Nail pitting,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1211,8,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1211,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1211,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1211,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1211,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1211,13,Product contamination microbial,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1211,14,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1211,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1211,16,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1212,1,Bacterial nail infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1212,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1212,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1212,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1212,5,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1212,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1212,7,Product contamination microbial,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1212,8,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
1212,9,Skin discharge,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1212,10,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1212,11,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1212,12,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1212,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1213,1,Headache,Headaches NEC,Headaches,Nerv,N
1214,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1215,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1215,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1215,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1215,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1215,5,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1215,6,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1216,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1216,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1216,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1216,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1216,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1216,6,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1216,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1216,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1216,9,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1216,10,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1216,11,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1216,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1217,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1217,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1217,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1217,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1218,1,Acne,Acnes,Skin appendage conditions,Skin,N
1218,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1218,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1218,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1218,5,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1218,6,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1218,7,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1218,8,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1218,9,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1218,10,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1218,11,Decorticate posture,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1218,12,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1218,13,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1218,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1218,15,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1218,16,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1218,17,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1218,18,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1218,19,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1218,20,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1218,21,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1218,22,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1218,23,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1218,24,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1218,25,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1218,26,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1218,27,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1218,28,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1218,29,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1218,30,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1218,31,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1218,32,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1218,33,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1218,34,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1219,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1220,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1220,2,Secondary immunodeficiency,Acquired immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
1220,3,Tinea infection,Tinea infections,Fungal infectious disorders,Infec,N
1221,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1222,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1222,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1222,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1222,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1223,1,Contraindicated device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1223,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1224,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1224,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1224,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1224,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1224,5,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1224,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1224,7,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1224,8,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1224,9,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1224,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1224,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1224,12,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1224,13,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
1224,14,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1224,15,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1224,16,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1225,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1226,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1227,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1227,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1227,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1228,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1228,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1229,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1229,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1229,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1229,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1229,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1229,6,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1230,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1230,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1230,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1230,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1230,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1230,6,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1230,7,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1230,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1231,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1232,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1232,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1232,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1232,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1233,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1233,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1233,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1233,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1234,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1234,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1234,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1234,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1234,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1234,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1234,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1234,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1234,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1234,10,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1234,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1234,12,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1234,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1234,14,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1234,15,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1234,16,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1234,17,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1234,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1235,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1236,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1236,2,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1236,3,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1236,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1236,5,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1236,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1236,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1236,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1236,9,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1236,10,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1237,1,Acne,Acnes,Skin appendage conditions,Skin,N
1237,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1237,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1237,4,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1237,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1237,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1237,7,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1237,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1237,9,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1237,10,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1237,11,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1237,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1237,13,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1237,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1237,15,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1237,16,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1237,17,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1238,1,Headache,Headaches NEC,Headaches,Nerv,N
1238,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1238,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1238,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1238,5,Pityriasis rosea,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1239,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1239,2,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
1239,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1239,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1239,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1240,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1240,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1240,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1241,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1241,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1241,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1241,4,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1241,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1241,6,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1241,7,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1241,8,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1241,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1241,10,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1241,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1241,12,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1241,13,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1241,14,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1242,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1242,3,Faecal calprotectin abnormal,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1243,1,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1244,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1244,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1244,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1244,4,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1244,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1244,6,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1244,7,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1244,8,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1244,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1244,10,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1244,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1244,12,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1244,13,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1244,14,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1245,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1246,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1246,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1246,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1246,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1247,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1247,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1248,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1248,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1249,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1250,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1251,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1251,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1251,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1252,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1252,2,Nikolsky's sign,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1252,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1253,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1253,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1253,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1253,4,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1253,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1253,6,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1253,7,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1253,8,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1253,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1253,10,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1253,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1253,12,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1253,13,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1253,14,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1254,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1254,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1254,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1254,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1254,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1255,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1255,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1255,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1255,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1255,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1255,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1255,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1255,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1255,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1255,10,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1255,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1256,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1256,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1256,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1256,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1256,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1256,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1256,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1256,8,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1256,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1257,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1257,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1257,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1257,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1257,5,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1257,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1257,7,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1257,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1257,9,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1257,10,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1258,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1258,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1258,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1258,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1258,5,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1259,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1259,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1259,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1259,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1259,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1259,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1259,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1259,8,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1259,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1260,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1260,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1260,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1260,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1260,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1261,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1261,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1261,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1261,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1261,5,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1261,6,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1261,7,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1261,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1261,9,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1261,10,Stoma site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1261,11,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1262,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1263,1,Anal blister,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1263,2,Anal erythema,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1263,3,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1263,4,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1264,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1264,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1265,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1265,2,Bipolar I disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1265,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1265,4,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1265,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1265,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1265,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1266,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1266,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1266,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1266,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1266,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1267,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1267,2,Headache,Headaches NEC,Headaches,Nerv,N
1267,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1267,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1267,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1267,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1267,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1267,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1267,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1268,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1268,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1268,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1269,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1270,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1270,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1270,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1270,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1270,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1270,6,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1270,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1270,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1270,9,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1271,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1271,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1271,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1271,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1271,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1271,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1271,7,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1272,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1273,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1273,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1274,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1274,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1274,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1274,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1275,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1275,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1275,3,Enzyme abnormality,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1275,4,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1275,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1275,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1275,7,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1275,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1275,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1275,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1275,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1275,12,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1275,13,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1275,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1275,15,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1275,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1275,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1275,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1276,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1276,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1276,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1276,4,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1276,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1276,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1276,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1277,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1277,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1277,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1277,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1277,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1277,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1277,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1277,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1277,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1278,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1278,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1278,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1279,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1279,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1279,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1279,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1280,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1280,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1280,3,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1281,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1282,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1282,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1282,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1282,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1283,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1283,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1283,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1283,4,Upper respiratory tract irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1284,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1285,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1285,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1285,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1285,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1286,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1286,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1287,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1287,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1288,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1289,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1289,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1290,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1290,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1290,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1290,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1290,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1290,6,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1290,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1290,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1290,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1290,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1290,11,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1290,12,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1290,13,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1290,14,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1290,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1290,16,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1290,17,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1290,18,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1290,19,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1290,20,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1290,21,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1290,22,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1291,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1291,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1291,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1291,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1291,5,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1291,6,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1291,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1291,8,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1291,9,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1291,10,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1291,11,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1291,12,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1291,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1291,14,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1291,15,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1291,16,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1292,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1293,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1294,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1294,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1294,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1295,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1295,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1295,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1296,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1296,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1296,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1296,4,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1297,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1297,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1298,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1298,2,Overgrowth fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1299,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1299,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1300,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1301,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1302,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1302,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1302,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1302,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1302,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1302,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1302,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1302,8,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1302,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1303,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1303,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1303,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1303,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1303,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1303,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1303,7,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1303,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1303,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1303,10,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1304,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
1304,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1304,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1305,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1306,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1306,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1306,3,Headache,Headaches NEC,Headaches,Nerv,N
1306,4,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1306,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1306,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1307,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1308,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1309,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1309,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1309,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1309,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1309,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1309,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1309,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1309,8,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
1309,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1309,10,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1310,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1310,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1310,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1310,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1310,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1310,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1311,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1311,2,Listless,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1311,3,Product contamination microbial,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1312,1,Application site odour,Application site reactions,Administration site reactions,Genrl,N
1312,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1312,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1312,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1312,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1312,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1312,7,Migraine,Migraine headaches,Headaches,Nerv,N
1312,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1312,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1312,10,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1312,11,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1313,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1313,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1313,3,Headache,Headaches NEC,Headaches,Nerv,N
1313,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1313,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1313,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1314,1,17-hydroxyprogesterone increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1314,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1314,3,Benign neoplasm of adrenal gland,Adrenal neoplasms benign,Endocrine neoplasms benign,Neopl,N
1314,4,Blood corticotrophin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1315,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1316,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1316,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1317,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1317,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1318,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1318,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1319,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1319,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1320,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1320,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1320,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1320,4,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
1320,5,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1320,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1320,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1321,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1321,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1321,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1321,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1321,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1321,6,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1321,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1321,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1321,9,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1321,10,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1321,11,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1321,12,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1321,13,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1321,14,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1321,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1321,16,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1321,17,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1321,18,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1321,19,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1321,20,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1321,21,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1321,22,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1321,23,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1321,24,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1321,25,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1321,26,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1321,27,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1321,28,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1322,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1322,2,Vaccination site swelling,Vaccination site reactions,Administration site reactions,Genrl,N
1322,3,Vaccination site warmth,Vaccination site reactions,Administration site reactions,Genrl,N
1323,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1323,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1324,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1324,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1325,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1325,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1326,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
1326,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1326,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1326,4,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1326,5,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1326,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1327,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1327,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1327,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1327,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1327,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1327,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1327,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1327,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1328,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1328,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1329,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1329,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1329,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1330,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1330,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1330,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1331,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1331,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1332,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1333,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1333,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1333,3,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1334,1,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1334,2,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1335,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1335,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1335,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1335,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1335,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1336,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1337,1,Blood sodium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1337,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1337,3,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1337,4,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1337,5,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1338,1,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1339,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1340,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1340,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1341,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1341,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1342,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1343,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1343,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1343,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1343,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1343,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1343,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1343,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1343,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1343,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1343,10,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1344,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1344,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1344,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1345,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1345,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1345,3,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1346,1,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1346,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1347,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1347,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1347,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1348,1,Application site nerve damage,Application site reactions,Administration site reactions,Genrl,N
1348,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1348,3,Application site scar,Application site reactions,Administration site reactions,Genrl,N
1348,4,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1348,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1348,6,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1348,7,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
1349,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1349,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1350,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1350,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1351,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1352,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1352,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1353,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1353,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1354,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1354,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1354,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1355,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1355,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1355,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1356,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1356,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1356,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1356,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1357,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1358,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1358,2,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1359,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1359,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1359,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1359,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1360,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1360,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1361,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1361,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1361,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1361,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1361,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1361,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1361,7,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1361,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1361,9,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1361,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1361,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1362,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1362,2,Inappropriate schedule of product discontinuation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1362,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1362,4,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1362,5,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1363,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1363,2,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1363,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1363,4,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1363,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1363,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1363,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1363,8,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1363,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1363,10,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1363,11,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1364,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1364,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1364,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1364,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1364,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1365,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1365,2,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1365,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1365,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1365,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1365,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1365,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1365,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1365,9,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1365,10,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1365,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1366,1,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1366,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1366,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1366,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1366,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1367,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1367,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1367,3,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
1368,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1368,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1368,3,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1369,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1369,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1369,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1369,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1369,5,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1370,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1370,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1370,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1370,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1371,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1371,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1371,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1371,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1371,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1371,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1371,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1371,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1371,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1371,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1371,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1371,12,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1371,13,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1372,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1372,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1373,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1373,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1373,3,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1373,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1373,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1373,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1373,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1373,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1373,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1373,10,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1373,11,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1373,12,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1373,13,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1373,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1373,15,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1373,16,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1373,17,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1373,18,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1374,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1374,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1375,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1375,2,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1376,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1376,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1376,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1376,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1376,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1376,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1376,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1377,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1377,2,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1377,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1377,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1377,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1377,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1377,7,Skin discharge,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1377,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1377,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1378,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1378,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1378,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1378,4,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1378,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1378,6,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1378,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1379,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1379,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1380,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1381,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1381,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1381,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1381,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1381,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1381,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1381,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1381,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1381,9,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
1381,10,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1381,11,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1381,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1382,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1382,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1382,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1382,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1382,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1383,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1383,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1383,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1383,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1383,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1383,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1383,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1384,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1384,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1384,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1384,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1384,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1385,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1385,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1386,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1386,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1386,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1386,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1386,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1386,6,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
1386,7,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1386,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1386,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1386,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1386,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1386,12,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1387,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1388,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1389,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1389,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1389,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1389,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1389,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1389,6,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
1390,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1391,1,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1392,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
1392,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1392,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1392,4,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1392,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1392,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1393,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1394,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1395,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1395,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1396,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1397,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1397,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1398,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1398,2,Laryngeal obstruction,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1399,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1399,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1400,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
1400,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1401,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1401,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1401,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1401,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1401,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1401,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1401,7,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1402,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1402,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1402,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1402,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1402,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1402,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1402,7,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1402,8,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1403,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1404,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
1404,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1405,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1405,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1405,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1405,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1405,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1405,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1405,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1405,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1405,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1405,10,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1405,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1405,12,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1405,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1405,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1405,15,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1406,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1407,1,Anal rash,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1408,1,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1408,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1409,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1409,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1409,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1410,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1410,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1410,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1410,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1410,5,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1411,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1412,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1412,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1412,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1412,4,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1412,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1412,6,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
1412,7,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1412,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1412,9,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1412,10,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
1413,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1413,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1413,3,Viral diarrhoea,Viral infections NEC,Viral infectious disorders,Infec,N
1413,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1414,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1414,2,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1414,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1414,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1414,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1414,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1414,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1414,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1414,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1414,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1414,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1415,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1415,2,Aversion,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1415,3,Aversion,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1415,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1415,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1415,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1415,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1415,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1415,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1415,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1415,11,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1415,12,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1415,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1416,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1416,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1417,1,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1417,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1418,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1419,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1419,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1419,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1419,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1419,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1420,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
1420,2,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
1421,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1422,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1422,2,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1423,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1424,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1425,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1425,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1425,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1426,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1426,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1426,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1426,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1426,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1427,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1427,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1427,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1427,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1427,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1427,6,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1427,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1427,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1427,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1427,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1427,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1427,12,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1427,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1427,14,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1428,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1428,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1429,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1429,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1429,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1430,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1430,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1431,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1431,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1431,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1431,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1431,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1431,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1431,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1431,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1431,9,Raoultella ornithinolytica infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1431,10,Serratia sepsis,Serratia infections,Bacterial infectious disorders,Infec,N
1431,11,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1432,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1432,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1432,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1432,4,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1433,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1433,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1434,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
1434,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1434,3,Necrotising enterocolitis neonatal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1434,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1434,5,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1435,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1435,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1435,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1436,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1437,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1437,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1438,1,Blood cortisol,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1439,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1440,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1441,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1441,2,Nipple disorder,Breast disorders NEC,Breast disorders,Repro,N
1441,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1441,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1441,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1442,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1442,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1442,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1442,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1442,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1442,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1442,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1442,8,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1442,9,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1443,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1444,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1444,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1445,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1445,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1445,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1446,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1446,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1446,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1446,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1446,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1446,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1446,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1447,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1447,2,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1447,3,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1448,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1448,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1448,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1448,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1448,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1448,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1448,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1448,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1448,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1448,10,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1448,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1448,12,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1448,13,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1448,14,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1448,15,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1448,16,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1448,17,Weight fluctuation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1449,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1449,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1449,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1449,4,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1449,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1449,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1449,7,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1449,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1449,9,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1449,10,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1449,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1449,12,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1450,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1450,2,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
1450,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1450,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1450,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1450,6,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1450,7,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1450,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1450,9,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1450,10,Multiple allergies,Allergic conditions NEC,Allergic conditions,Immun,N
1450,11,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1450,12,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1450,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1450,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1450,15,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1450,16,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1450,17,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1450,18,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1450,19,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1450,20,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1451,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1451,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1451,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1451,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1451,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1451,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1451,7,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1451,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1451,9,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1451,10,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1451,11,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1452,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1452,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1453,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1454,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1455,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1456,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1457,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1457,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1457,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1458,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1459,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1460,1,Atopic keratoconjunctivitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1461,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1461,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1461,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1461,4,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1462,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1463,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1463,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1463,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1463,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1463,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1463,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1463,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1463,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1463,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1463,10,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1463,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1463,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1464,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1464,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1465,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1465,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1466,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1466,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1467,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1468,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1469,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1470,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1470,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1471,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1471,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1471,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1472,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1472,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1472,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1472,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1472,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1472,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1472,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1472,8,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1473,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
1474,1,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1475,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1476,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1476,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1476,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1476,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1477,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1477,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1477,3,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1477,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1477,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1478,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1479,1,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1480,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1480,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1480,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1481,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1482,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1482,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1483,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1484,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1484,2,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1484,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1484,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1484,5,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1484,6,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1485,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1486,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1486,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1486,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1487,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1487,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1487,3,Penile pain,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
1487,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1487,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1487,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1488,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1489,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1489,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1489,3,Headache,Headaches NEC,Headaches,Nerv,N
1489,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1490,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1490,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1490,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1491,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1491,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1491,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1491,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1491,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1491,6,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1492,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1492,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1493,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1494,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1494,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1494,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1494,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1494,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1494,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1494,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1494,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1494,9,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1494,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1495,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1495,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1495,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1496,1,Faecal elastase concentration abnormal,Digestive enzymes,Gastrointestinal investigations,Inv,N
1497,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1497,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1497,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1497,4,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
1497,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1497,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1498,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1498,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1498,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1498,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1498,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1498,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1498,7,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1498,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1498,9,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1498,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1498,11,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1498,12,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1499,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1499,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1499,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1499,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1500,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1500,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1500,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1501,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1502,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1502,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1502,3,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1502,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1503,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1503,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1503,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1504,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1505,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1506,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1506,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1507,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1507,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1508,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1508,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1508,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1508,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1508,5,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1508,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1509,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1510,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1510,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1511,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
1511,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1511,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1511,4,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1511,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1511,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1512,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1513,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1514,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1514,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1514,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1514,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1515,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1515,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1515,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1515,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1516,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1517,1,Hypercoagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1518,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1518,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1519,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1520,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1520,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1520,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1520,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1520,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1520,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1520,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1520,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1520,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1520,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1520,11,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1521,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1521,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1521,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1521,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1522,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1522,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1522,3,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1523,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1523,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1524,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1525,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1526,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1527,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1527,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1528,1,Allergy to chemicals,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1528,2,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1528,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1528,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1528,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1528,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1528,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1528,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1528,9,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1528,10,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1528,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1528,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1528,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1529,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1530,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1530,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1531,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1531,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1531,3,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
1532,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1532,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1533,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1534,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1534,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1534,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1534,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1535,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1536,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1537,1,Vulval haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1537,2,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1538,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1538,2,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1538,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
1539,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1540,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1540,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1540,3,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
1541,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1541,2,Headache,Headaches NEC,Headaches,Nerv,N
1541,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1541,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1542,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1543,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1544,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1544,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1545,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1546,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1546,2,Acne,Acnes,Skin appendage conditions,Skin,N
1546,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1546,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1546,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1546,6,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1546,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1546,8,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
1546,9,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1546,10,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1546,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1546,12,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1546,13,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1546,14,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1546,15,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1546,16,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1546,17,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1546,18,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1546,19,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1546,20,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1546,21,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1546,22,Headache,Headaches NEC,Headaches,Nerv,N
1546,23,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1546,24,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1546,25,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1546,26,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1546,27,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1546,28,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1546,29,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1546,30,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1546,31,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1546,32,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1546,33,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1546,34,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1546,35,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1546,36,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1546,37,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1546,38,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1546,39,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1546,40,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1546,41,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1546,42,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1546,43,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1547,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1547,2,Elephantiasis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1547,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1547,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1547,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1547,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1547,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1547,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1547,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1547,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1547,11,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1547,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1547,13,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1548,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1548,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1548,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1549,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1549,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1550,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1550,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1550,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1550,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1550,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1550,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1550,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1550,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1550,9,Sweating fever,Viral infections NEC,Viral infectious disorders,Infec,N
1551,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1551,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1551,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1552,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1552,2,Acne,Acnes,Skin appendage conditions,Skin,N
1552,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1552,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1552,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1552,6,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1552,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1552,8,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
1552,9,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1552,10,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1552,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1552,12,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1552,13,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1552,14,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1552,15,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1552,16,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1552,17,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1552,18,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1552,19,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1552,20,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1552,21,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1552,22,Headache,Headaches NEC,Headaches,Nerv,N
1552,23,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1552,24,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1552,25,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1552,26,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1552,27,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1552,28,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1552,29,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1552,30,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1552,31,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1552,32,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1552,33,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1552,34,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1552,35,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1552,36,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1552,37,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1552,38,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1552,39,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1552,40,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1552,41,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1552,42,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1552,43,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1553,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1554,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1554,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1555,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1556,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1557,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1558,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1559,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1560,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1560,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1560,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1560,4,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1560,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1560,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1560,7,Product advertising issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1560,8,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
1560,9,Product intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1560,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1560,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1560,12,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1560,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1560,14,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1560,15,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1560,16,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1560,17,Urticaria aquagenic,Urticarias,Angioedema and urticaria,Skin,N
1561,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1561,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1561,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1562,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1563,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1563,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1563,3,Gastritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1563,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1563,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1563,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1563,7,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1563,8,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1563,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1564,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1564,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1565,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1565,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1565,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1566,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1567,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1568,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1569,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1569,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1569,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1569,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1569,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1570,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1570,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1570,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1570,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1570,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1570,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1570,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1570,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1570,9,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1570,10,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1571,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1571,2,Device defective,Device physical property and chemical issues,Device issues,Prod,N
1571,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1571,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1572,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1572,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1573,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1574,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1575,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1575,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1575,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1575,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1575,5,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1575,6,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1576,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1577,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1578,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1578,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1578,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1578,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1578,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1578,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1578,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1578,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1578,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1578,10,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1578,11,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1578,12,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1578,13,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1578,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1578,15,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1578,16,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1578,17,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1578,18,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1578,19,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1578,20,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1578,21,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1578,22,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1578,23,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1579,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
1579,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1580,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1580,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1581,1,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1582,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1582,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1583,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1583,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1584,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1584,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1584,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1584,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1584,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1584,6,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1584,7,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1584,8,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1585,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1585,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1586,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1586,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1586,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1586,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1586,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1587,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1588,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1589,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1589,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1589,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1589,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1590,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1590,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1591,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1592,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1592,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1592,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1592,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1592,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1592,6,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1592,7,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1592,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1593,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1594,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1594,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1595,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1595,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1595,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1596,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1596,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1596,3,Headache,Headaches NEC,Headaches,Nerv,N
1596,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1596,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1596,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1596,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1596,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1596,9,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1596,10,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1596,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1597,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1597,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1597,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1597,4,Helplessness,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1597,5,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1597,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1597,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1597,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1597,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1597,10,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1598,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1598,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1598,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1598,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1599,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1600,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1600,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1600,3,Headache,Headaches NEC,Headaches,Nerv,N
1600,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1600,5,Mental fatigue,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1601,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1601,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1601,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1601,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1602,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1603,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1604,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1605,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1605,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1605,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1605,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1606,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1607,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1608,1,Corneal erosion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1608,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1608,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1608,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1608,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1608,6,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1608,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1608,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1608,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1609,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1609,2,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1609,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1609,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1609,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1609,6,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1609,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1609,8,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1609,9,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1609,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1609,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1609,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1609,13,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1609,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1609,15,SARS-CoV-2 test negative,Virus identification and serology,Microbiology and serology investigations,Inv,N
1609,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1610,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1610,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1611,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1611,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1611,3,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1611,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1612,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1613,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1614,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1614,2,Precancerous cells present,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1614,3,Radiotherapy,Radiotherapies site unspecified,Therapeutic procedures and supportive care NEC,Surg,N
1615,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1615,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1616,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1617,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1617,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1617,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1617,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1617,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1617,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1617,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1617,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1617,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1617,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1617,11,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1617,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1617,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1617,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1617,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1617,16,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1617,17,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1617,18,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1617,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1618,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1618,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1618,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1619,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1620,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1621,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1621,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1621,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1621,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1621,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1621,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1621,7,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1621,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1621,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1621,10,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1621,11,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1621,12,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1621,13,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1622,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1622,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1623,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1624,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1625,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1626,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1627,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1628,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1628,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1628,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1629,1,Dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1629,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1630,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1630,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1631,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1631,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1631,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1631,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1631,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1631,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1631,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1632,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1632,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1632,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1632,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1633,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1633,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1633,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1633,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1633,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1634,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1634,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1635,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1635,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1635,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1635,4,Epinephrine increased,Adrenal medulla tests,Endocrine investigations (incl sex hormones),Inv,N
1635,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1635,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1635,7,Madarosis,Alopecias,Skin appendage conditions,Skin,N
1635,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1635,9,Mental fatigue,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1635,10,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1635,11,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1635,12,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1635,13,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1635,14,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1635,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1635,16,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1635,17,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1635,18,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1635,19,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1635,20,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1635,21,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1635,22,Skin temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1635,23,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1635,24,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1635,25,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1635,26,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1636,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1637,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1637,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1637,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1637,4,Eczema asteatotic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1637,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1637,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1637,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1637,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1637,9,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1637,10,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1637,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1637,12,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1637,13,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1637,14,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1637,15,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1637,16,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1637,17,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1638,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1638,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1639,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1640,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1640,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1641,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1641,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1641,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1642,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1642,2,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1642,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1643,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1644,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1645,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1646,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1647,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1647,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1647,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1647,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1647,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1648,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1648,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1648,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1648,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1648,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1648,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1648,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1648,8,Rebound eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1648,9,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1648,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1648,11,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1648,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1649,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1649,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1650,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1651,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1651,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1652,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1652,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1652,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1653,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1653,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1653,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1653,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1653,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1653,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1653,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1653,8,Rebound eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1653,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1653,10,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1653,11,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1653,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1654,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1654,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1655,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1656,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1656,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1656,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1657,1,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1657,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1657,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1657,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1658,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1658,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1658,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1659,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1660,1,17-hydroxyprogesterone increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1661,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1661,2,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1661,3,Headache,Headaches NEC,Headaches,Nerv,N
1661,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1662,1,17-hydroxyprogesterone increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1662,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1662,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1663,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1664,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1664,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1664,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1664,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1665,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1666,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1666,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1667,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1668,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1669,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1669,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1669,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1669,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1669,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1669,6,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1669,7,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1669,8,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1669,9,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1669,10,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1669,11,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1669,12,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1669,13,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1669,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1669,15,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1669,16,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1669,17,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1669,18,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1669,19,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1669,20,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1669,21,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1669,22,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1669,23,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1669,24,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1669,25,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1669,26,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1669,27,Weight fluctuation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1670,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1671,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1671,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1672,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1673,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1673,2,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
1674,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1675,1,Chronic myelomonocytic leukaemia,Myelodysplastic syndromes,Leukaemias,Neopl,N
1676,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1677,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1677,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1677,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1678,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1678,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1678,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1679,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1679,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1679,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1679,4,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1680,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1681,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1682,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1682,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1682,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1683,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1684,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1684,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1685,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1686,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1687,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1687,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1687,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1687,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1687,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1687,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1687,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1687,8,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1687,9,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1687,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1687,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1687,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1687,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1687,14,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1688,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1688,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1688,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1688,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1688,5,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1689,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1689,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1689,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1689,4,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1689,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1689,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1689,7,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1689,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1689,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1689,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1689,11,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1689,12,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1689,13,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1689,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1689,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1689,16,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1689,17,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1689,18,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1689,19,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1690,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1690,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1691,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1692,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1693,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1693,2,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1694,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1695,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1696,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1697,1,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1697,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1698,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1698,2,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1698,3,Acne,Acnes,Skin appendage conditions,Skin,N
1698,4,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1698,5,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1698,6,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1698,7,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1698,8,Claustrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1698,9,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1698,10,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
1698,11,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1698,12,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1698,13,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1698,14,External fixation of fracture,Fracture treatments (excl skull and spine),Bone and joint therapeutic procedures,Surg,N
1698,15,Feeling of relaxation,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1698,16,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1698,17,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1698,18,Hyperphagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1698,19,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1698,20,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1698,21,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
1698,22,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1698,23,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1698,24,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1698,25,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1698,26,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1698,27,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1698,28,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1699,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1699,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1699,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1700,1,Headache,Headaches NEC,Headaches,Nerv,N
1700,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1701,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1702,1,Blood corticotrophin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1702,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1702,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1702,4,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1702,5,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1703,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1703,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1704,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1704,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1705,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1705,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1705,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1705,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1705,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1705,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1705,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1706,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1706,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1706,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1706,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1706,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1706,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1707,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1707,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1707,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1708,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1708,2,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1708,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1708,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1708,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1708,6,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1708,7,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1708,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1708,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1708,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1708,11,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1708,12,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1708,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1708,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1708,15,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1708,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1708,17,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1708,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1708,19,SARS-CoV-2 test negative,Virus identification and serology,Microbiology and serology investigations,Inv,N
1708,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1709,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1710,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1710,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1710,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1710,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1710,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1711,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1712,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1713,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1713,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1713,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1713,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1714,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1715,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1715,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1716,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1716,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1716,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1716,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1717,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1718,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1718,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1718,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1719,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1719,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1720,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1720,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1721,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1721,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1722,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1722,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1722,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1723,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1724,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1724,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1724,3,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1724,4,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1724,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1724,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1724,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1724,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1724,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1724,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1724,11,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1724,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1724,13,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1724,14,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1724,15,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1724,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1725,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1726,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1726,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1727,1,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1728,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1728,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1729,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1729,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1729,3,Blood antidiuretic hormone,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
1729,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1729,5,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1729,6,Headache,Headaches NEC,Headaches,Nerv,N
1729,7,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1729,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1729,9,Hypertensive emergency,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
1729,10,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1729,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1730,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1730,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1730,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1730,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1730,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1730,6,Multiple allergies,Allergic conditions NEC,Allergic conditions,Immun,N
1730,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1730,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1730,9,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1730,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1730,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1730,12,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1730,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1730,14,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1730,15,Sticky skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1730,16,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1730,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1730,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1731,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1731,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1732,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1732,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1733,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1733,2,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1733,3,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1733,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1734,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1735,1,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1735,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1736,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1736,2,Headache,Headaches NEC,Headaches,Nerv,N
1736,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1736,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1736,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1737,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1738,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1739,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1739,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1740,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1740,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1741,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1741,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1742,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1743,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1744,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1744,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1745,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1745,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1746,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1747,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1747,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1748,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1748,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1749,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1749,2,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1749,3,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1749,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1749,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1749,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1749,7,Genital swelling,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1749,8,Immobile,Disability issues,Lifestyle issues,SocCi,N
1749,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1749,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1749,11,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1749,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1749,13,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1749,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1749,15,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1749,16,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1750,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1751,1,Bone marrow oedema syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
1751,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1752,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1752,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1752,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1753,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1754,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1754,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1754,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1754,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1754,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1755,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1755,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1756,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1757,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1757,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1758,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1758,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1759,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1759,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1759,3,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1759,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1759,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1759,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1759,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1759,8,Necrotising retinitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1759,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1759,10,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1759,11,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1759,12,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1759,13,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1759,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1759,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1759,16,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1760,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1761,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1761,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1762,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1762,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1762,3,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1763,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1764,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1764,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1764,3,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1764,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1764,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1764,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1764,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1765,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1766,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1766,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1766,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1767,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1767,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1767,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1767,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1767,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1767,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1767,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1767,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1767,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1767,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1767,11,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1767,12,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1767,13,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1767,14,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1767,15,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1767,16,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1767,17,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1767,18,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1768,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1768,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1769,1,Product blister packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1769,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1770,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1771,1,Penile erythema,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
1772,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1773,1,Headache,Headaches NEC,Headaches,Nerv,N
1773,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1773,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1773,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1773,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1773,6,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1773,7,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1773,8,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1773,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1774,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1775,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1775,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1775,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1775,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1775,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1775,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1775,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1775,8,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1775,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1775,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1775,11,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1775,12,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1775,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1775,14,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1775,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1775,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1776,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1776,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1776,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1776,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1776,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1776,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1776,7,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1777,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1778,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1778,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1778,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1778,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1779,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1780,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1780,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1781,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1781,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1782,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1782,2,Product confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1782,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1783,1,Genital erythema,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1783,2,Genital lesion,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
1784,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1784,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1784,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1784,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1784,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1784,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1784,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1784,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1784,9,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1784,10,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1785,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1785,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1785,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1785,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1786,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1787,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1787,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1787,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1788,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1789,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1790,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1791,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1792,1,Anal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1793,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1794,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1794,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1794,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1794,4,Headache,Headaches NEC,Headaches,Nerv,N
1794,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1794,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1794,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1794,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1795,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1796,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1796,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1796,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1796,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1796,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1796,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1796,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1796,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1796,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1796,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1796,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1797,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1798,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1798,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1798,3,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1798,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1798,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1799,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1800,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1800,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1801,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1802,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1802,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1802,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1802,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1803,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1803,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1803,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1803,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1804,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1804,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1805,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1806,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1807,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1807,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
